Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Parasitology and Mycology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
BMC Infect Dis. 2024 Jan 3;24(1):42. doi: 10.1186/s12879-023-08964-9.
Toxoplasmosis is a serious or life-threatening disease in immunosuppressed patients and pregnant women. This study examined the likely association between Toxoplasma gondii infection and COVID-19 patients with moderate illness.
Seventy blood samples were collected from patients at the Health Reference Laboratory of Tabriz, Northwest Iran from April 2021 to September 2021. In addition, 70 healthy subjects of the same age (37 ± 15 years) and sex distribution were ethnically matched. Sera samples were examined for the detection of anti-Toxoplasma antibodies using ELISA. Nested-PCR targets were amplified based on the B1 and GRA6 genes. GRA6 amplicons were subjected to sequencing and phylogenetic analysis.
The seroprevalence of toxoplasmosis based on IgG titer was 35.7% in the COVID‑19 patients and 27.1% in the control group, representing not to be associated with the Toxoplasma seropositivity in COVID‑19 patients (P = 0.18) compared to healthy subjects. Anti-T. gondii IgM was not found in any of the patients and healthy individuals. According to PCR amplification of the B1 and GRA6 genes, the frequency of T. gondii in COVID-19 patients was 14.2% (10/70). However, no T. gondii infection was detected in the healthy group. The CD4T cell count was relatively lower in toxoplasmosis-infected patients (430-450 cells/mm3) than in control group (500-1500 cells/mm3). High genetic diversity (Hd: 0.710) of the type I strain of T. gondii was characterized in the patients. Present results showed that consumption of raw vegetables and close contact with stray cats can increase the transmission of T. gondii to COVID-19 patients (P < 0.01).
The current study revealed that T. gondii type I infection is unequivocally circulating among the COVID-19 patients in Tabriz; However, no significant association was observed between the occurrence of Toxoplasma and the severity of COVID-19. To make more accurate health decisions, multicenter investigations with a larger sample size of different ethnic groups of the Iranian population are needed.
弓形体病在免疫抑制患者和孕妇中是一种严重或危及生命的疾病。本研究旨在探讨刚地弓形虫感染与中度 COVID-19 患者之间的可能关联。
本研究于 2021 年 4 月至 9 月在伊朗西北部大不里士健康参考实验室采集了 70 例患者的血液样本。此外,还选择了 70 名相同年龄(37±15 岁)和性别分布的健康对照者。采用酶联免疫吸附试验(ELISA)检测血清样本中抗弓形体抗体。巢式 PCR 扩增 B1 和 GRA6 基因。对 GRA6 扩增子进行测序和系统进化分析。
根据 IgG 滴度,COVID-19 患者的弓形体病血清阳性率为 35.7%,对照组为 27.1%,与健康对照组相比,COVID-19 患者的弓形体血清阳性率无显著相关性(P=0.18)。未在任何患者和健康个体中发现抗 T. gondii IgM。根据 B1 和 GRA6 基因的 PCR 扩增,COVID-19 患者的刚地弓形虫感染率为 14.2%(10/70)。然而,在健康组中未检测到刚地弓形虫感染。与对照组(500-1500 个细胞/mm3)相比,感染刚地弓形虫的患者 CD4T 细胞计数相对较低(430-450 个细胞/mm3)。患者中 I 型刚地弓形虫的遗传多样性较高(Hd:0.710)。结果表明,食用生蔬菜和与流浪猫密切接触会增加 COVID-19 患者感染刚地弓形虫的风险(P<0.01)。
本研究表明,I 型刚地弓形虫感染在大不里士的 COVID-19 患者中广泛传播;然而,刚地弓形虫的发生与 COVID-19 的严重程度之间没有显著关联。为了做出更准确的健康决策,需要对不同种族的伊朗人群进行更大规模的多中心研究。